Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China · Delayed Price · Currency is CNY 94.42
-1.87 (-1.94%)
Feb 13, 2026, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 24.99 billion as of February 13, 2026. Its market cap has increased by 47.53% in one year.
Market Cap
24.99B
Enterprise Value
24.03B
Revenue
742.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
94.42
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 24.99B, an increase of 39.62%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 24.99B | 1.86% |
| Dec 31, 2025 | 24.54B | 48.77% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) | 36.34B |
| Asymchem Laboratories (Tianjin) | 35.38B |
| Beijing Tiantan Biological Products | 32.23B |
| Xiamen Amoytop Biotech | 29.55B |
| Hualan Biological Engineering | 27.98B |
| Yili Chuanning Biotechnology | 24.35B |
| DaShenLin Pharmaceutical Group | 21.89B |
| BrightGene Bio-Medical Technology | 19.17B |